US Stock MarketDetailed Quotes

AIM AIM ImmunoTech

Watchlist
  • 0.2280
  • +0.0030+1.33%
Close Nov 27 16:00 ET
  • 0.2281
  • +0.0001+0.04%
Post 18:02 ET
14.53MMarket Cap-485P/E (TTM)

AIM ImmunoTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-23.91%35K
19.05%50K
-18.37%40K
43.26%202K
16.07%65K
119.05%46K
40.00%42K
48.48%49K
4.44%141K
12.00%56K
Operating revenue
-23.91%35K
19.05%50K
-18.37%40K
43.26%202K
16.07%65K
119.05%46K
40.00%42K
48.48%49K
4.44%141K
12.00%56K
Cost of revenue
-73.33%8K
8K
8K
42K
12K
30K
0
0
0
0
Gross profit
68.75%27K
0.00%42K
-34.69%32K
13.48%160K
-5.36%53K
-23.81%16K
207.69%42K
211.36%49K
119.72%141K
144.44%56K
Operating expense
-44.74%4.52M
-32.11%3.74M
32.73%5.77M
59.87%32.08M
150.48%14.06M
24.93%8.17M
18.19%5.5M
39.77%4.34M
22.76%20.06M
1.30%5.61M
Selling and administrative expenses
-43.39%3.08M
1.61%2.59M
66.45%3.82M
61.67%21.14M
209.76%10.86M
5.20%5.44M
16.92%2.55M
10.62%2.29M
50.76%13.07M
33.93%3.51M
-General and administrative expense
-43.39%3.08M
1.61%2.59M
66.45%3.82M
61.67%21.14M
209.76%10.86M
5.20%5.44M
16.92%2.55M
10.62%2.29M
50.76%13.07M
33.93%3.51M
Research and development costs
-47.44%1.44M
-61.23%1.15M
-4.92%1.95M
56.49%10.94M
51.87%3.2M
99.27%2.73M
19.31%2.95M
98.07%2.05M
-8.89%6.99M
-27.92%2.11M
Operating profit
44.97%-4.49M
32.36%-3.69M
-33.50%-5.73M
-60.20%-31.92M
-152.05%-14M
-25.09%-8.16M
-16.32%-5.46M
-36.26%-4.3M
-16.79%-19.92M
1.94%-5.56M
Net non-operating interest income expense
75.51%516K
655.03%2.4M
-95.48%9K
69.95%1.07M
-22.52%258K
70.93%294K
302.53%318K
342.22%199K
1,038.81%629K
433.00%333K
Non-operating interest income
144.22%718K
711.32%2.58M
-59.30%81K
69.95%1.07M
-22.52%258K
70.93%294K
302.53%318K
342.22%199K
--629K
433.00%333K
Non-operating interest expense
--202K
--179K
--72K
----
----
--0
--0
--0
----
----
Other net income (expense)
480.85%273K
-332.05%-543K
-121.15%-92K
1,348.34%1.89M
40.29%1.17M
230.56%47K
199.57%234K
161.01%435K
92.45%-151K
1,142.50%834K
Gain on sale of security
188.06%273K
-477.66%-543K
-145.32%-92K
112.17%200K
345.56%401K
14.84%-310K
79.87%-94K
122.48%203K
-2,835.71%-1.64M
215.38%90K
Special income (charges)
--0
--0
--0
500.00%18K
-33.33%2K
--39K
--0
---23K
100.07%3K
100.17%3K
-Gain on sale of property,plant,equipment
--0
--0
--0
500.00%18K
-33.33%2K
--39K
--0
---23K
-98.61%3K
--3K
Other non- operating income (expenses)
----
----
----
11.88%1.67M
3.51%767K
-3.05%318K
41.38%328K
34.21%255K
-35.75%1.49M
-58.30%741K
Income before tax
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
Income tax
Net income
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
Net income continuous Operations
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
Minority interest income
Net income attributable to the parent company
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
52.66%-3.7M
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
Basic earnings per share
62.50%-0.06
70.00%-0.03
-50.00%-0.12
-50.00%-0.6
-188.89%-0.26
-23.08%-0.16
0.00%-0.1
0.00%-0.08
0.00%-0.4
25.00%-0.09
Diluted earnings per share
62.50%-0.06
70.00%-0.03
-50.00%-0.12
-50.00%-0.6
-188.89%-0.26
-23.08%-0.16
0.00%-0.1
0.00%-0.08
0.00%-0.4
25.00%-0.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -23.91%35K19.05%50K-18.37%40K43.26%202K16.07%65K119.05%46K40.00%42K48.48%49K4.44%141K12.00%56K
Operating revenue -23.91%35K19.05%50K-18.37%40K43.26%202K16.07%65K119.05%46K40.00%42K48.48%49K4.44%141K12.00%56K
Cost of revenue -73.33%8K8K8K42K12K30K0000
Gross profit 68.75%27K0.00%42K-34.69%32K13.48%160K-5.36%53K-23.81%16K207.69%42K211.36%49K119.72%141K144.44%56K
Operating expense -44.74%4.52M-32.11%3.74M32.73%5.77M59.87%32.08M150.48%14.06M24.93%8.17M18.19%5.5M39.77%4.34M22.76%20.06M1.30%5.61M
Selling and administrative expenses -43.39%3.08M1.61%2.59M66.45%3.82M61.67%21.14M209.76%10.86M5.20%5.44M16.92%2.55M10.62%2.29M50.76%13.07M33.93%3.51M
-General and administrative expense -43.39%3.08M1.61%2.59M66.45%3.82M61.67%21.14M209.76%10.86M5.20%5.44M16.92%2.55M10.62%2.29M50.76%13.07M33.93%3.51M
Research and development costs -47.44%1.44M-61.23%1.15M-4.92%1.95M56.49%10.94M51.87%3.2M99.27%2.73M19.31%2.95M98.07%2.05M-8.89%6.99M-27.92%2.11M
Operating profit 44.97%-4.49M32.36%-3.69M-33.50%-5.73M-60.20%-31.92M-152.05%-14M-25.09%-8.16M-16.32%-5.46M-36.26%-4.3M-16.79%-19.92M1.94%-5.56M
Net non-operating interest income expense 75.51%516K655.03%2.4M-95.48%9K69.95%1.07M-22.52%258K70.93%294K302.53%318K342.22%199K1,038.81%629K433.00%333K
Non-operating interest income 144.22%718K711.32%2.58M-59.30%81K69.95%1.07M-22.52%258K70.93%294K302.53%318K342.22%199K--629K433.00%333K
Non-operating interest expense --202K--179K--72K----------0--0--0--------
Other net income (expense) 480.85%273K-332.05%-543K-121.15%-92K1,348.34%1.89M40.29%1.17M230.56%47K199.57%234K161.01%435K92.45%-151K1,142.50%834K
Gain on sale of security 188.06%273K-477.66%-543K-145.32%-92K112.17%200K345.56%401K14.84%-310K79.87%-94K122.48%203K-2,835.71%-1.64M215.38%90K
Special income (charges) --0--0--0500.00%18K-33.33%2K--39K--0---23K100.07%3K100.17%3K
-Gain on sale of property,plant,equipment --0--0--0500.00%18K-33.33%2K--39K--0---23K-98.61%3K--3K
Other non- operating income (expenses) ------------11.88%1.67M3.51%767K-3.05%318K41.38%328K34.21%255K-35.75%1.49M-58.30%741K
Income before tax 52.66%-3.7M62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M
Income tax
Net income 52.66%-3.7M62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M
Net income continuous Operations 52.66%-3.7M62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M
Minority interest income
Net income attributable to the parent company 52.66%-3.7M62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 52.66%-3.7M62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M
Basic earnings per share 62.50%-0.0670.00%-0.03-50.00%-0.12-50.00%-0.6-188.89%-0.26-23.08%-0.160.00%-0.10.00%-0.080.00%-0.425.00%-0.09
Diluted earnings per share 62.50%-0.0670.00%-0.03-50.00%-0.12-50.00%-0.6-188.89%-0.26-23.08%-0.160.00%-0.10.00%-0.080.00%-0.425.00%-0.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Cannabis & Hemp
Cannabis & Hemp
Intraday+0.07%